Skip to main content

and
  1. Article

    Open Access

    Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors

    Pituitary neuroendocrine tumors (PitNETs) exhibiting aggressive, treatment-refractory behavior are the rare subset that progress after surgery, conventional medical therapies, and an initial course of radiatio...

    Andrew L. Lin, Vasilisa A. Rudneva, Allison L. Richards in Acta Neuropathologica (2024)

  2. Article

    Open Access

    Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapy

    Reversion mutations that restore wild-type function of the BRCA gene have been described as a key mechanism of resistance to Poly(ADP-ribose) polymerase (PARP) inhibitor therapy in BRCA-associated cancers. Here, ...

    Charlotte S. Walmsley, Philip Jonsson, Michael L. Cheng in npj Precision Oncology (2024)